Neoadjuvant cryotherapy improves dysphagia and may impact remission rates in advanced esophageal cancer
Conclusions LNSC provided safe and effective palliation for esophageal cancer patients who presented with dysphagia at index diagnosis. Its combination with chemoradiotherapy did not lead to any serious toxicity. Our study provides a scientific rationale for pursuing larger clinical trials addressing synergistic effects of combining LNSC with chemoradiation. [...] © Georg Thieme Verlag KG Stuttgart · New YorkArticle in Thieme eJournals: Table of contents | Abstract | open access Full text
Source: Endoscopy International Open - Category: Gastroenterology Authors: Shah, Tilak Kushnir, Vladimir Mutha, Pritesh Majhail, Mankanchan Patel, Bhaumik Schutzer, Matthew Mogahanaki, Drew Smallfield, George Patel, Milan Zfass, Alvin Tags: Original article Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Cryotherapy | Endoscopy | Esophagus Cancer | Gastroenterology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Toxicology